<DOC>
	<DOC>NCT01831609</DOC>
	<brief_summary>To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches.</brief_summary>
	<brief_title>Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>1. Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer 2. Written informed consent 3. body fluid derived from cancer, available for drainage and collection patients who do not give informed consent form for research use of biomaterials/biospecimens</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Gastrointestinal</keyword>
	<keyword>Genitourinary</keyword>
	<keyword>Rare Cancer</keyword>
</DOC>